Additionally, a recent study showed that a low expression level of ST3GAL5 correlates with increased tumorigenesis and progression of bladder cancer, highlighting its potential as a predictive biomarker as well as a therapeutic target [41]. This evidence concerns the gene ST3GAL5 and urinary bladder cancer.